Clinical Trials Logo
  1. Home
  2. Stress Hyperglycemia
  3. NCT02946411
  4. Details
NCT02946411 Clinical Trial

Correlation of Hospital Stay Length With the Glucose Levels After Cardiac Surgery

Stress Hyperglycemia Clinical Trial

Official title:
Correlation of Hospital Stay Length With the Glucose Measured Continuously Levels After Cardiac Surgery

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number NCT02946411
Other study ID # R-2016-785.080
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date November 1, 2016
Est. completion date December 2021

Study information
Verified date August 2020
Source Coordinación de Investigación en Salud, Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is designed to test if there is any correlation between the glucose levels in the postoperatory period and the length of hospital stay.

Description:

The stress hyperglycemia commonly observed in the postoperatory period, there have been several studies to assess if there is benefit of having a strict glucose control or not.

This study will assess if there is correlation between the glucose levels measured continuously with the length of the stay in the hospital.

Recruitment information / eligibility
Status Enrolling by invitation
Enrollment 48
Est. completion date December 2021
Est. primary completion date December 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

- Physical status classification of the American Society of Anesthesiologists (ASA) II-IV

- Patients programmed for cardiac surgery

- Any body mass index

Exclusion Criteria:

- Pregnant women

- Chronic Kidney Disease (CKD) Stage 2 or higher

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Cardiac surgery
Glucose level will be measured after cardiac surgery.

Locations
Country Name City State
Mexico Hospital de cardiología Ciudad de mexico Cdmx

Sponsors (1)
Lead Sponsor Collaborator
Coordinación de Investigación en Salud, Mexico

Country where clinical trial is conducted

Mexico, 

Outcome
Type Measure Description Time frame Safety issue
Primary Glucose Glucose will be continuously monitored for 5 days 5 days
Secondary Hospital stay The days that the patient remains in the hospital after the surgery. [Days] Within the first 20 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT04408768 - Stress Hyperglycemia and Acute Ischemic Stroke
Terminated NCT03743025 - Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients Phase 4
Completed NCT02726958 - Early Postoperative Blood Glucose Variability and Outcome After TAVI N/A
Not yet recruiting NCT05314725 - Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial Phase 2
Completed NCT01969149 - Exenatide for Stress Hyperglycemia Phase 2/Phase 3
Not yet recruiting NCT01776476 - A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma Phase 2
Terminated NCT02068989 - Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus N/A
Completed NCT02847104 - Medical ICU Paper-based Dynamic Insulin Protocol N/A
Recruiting NCT02180555 - Diabetes Mellitus After Intensive Care Admission N/A
Not yet recruiting NCT04591561 - Incidence and Course of Stress Hyperglycemia in Critically Ill Children Admitted to PICU of Assiut University Children Hospital